WFSBP 2021 Preliminary Program

14 WFSBP 2021 Preliminary Scientific Program / Symposia S-04-003 The effects of LSD microdosing on cognitive, subjective and biological parameters in healthy volunteers Kim Kuypers, The Netherlands S-04-004 Clinical and neurobiological predictors of antidepres- sant response to Ketamine Jiri Horacek, Czech Republic T14: DEPRESSION: BASIC/CLINICAL S-05 07:30–09:00 Big biological data, data integration and learning algorithms in deciphering major depression and its treatments Chair: Gabriella Juhasz, Hungary Co-Chair: Hiroshi Mamitsuka, Japan S-05-001 Health risk assessment in somatic and mental comorbid- ities: Population based studies in Catalonia Isaac Cano, Spain S-05-002 Gene-environment interactions as stratification variables behind depression Sandra van der Auwera-Palitschka, Germany S-05-003 Effects of polymorphisms depend on stress exposure: An example of the use of Bayesian learning algorithms Xenia Gonda, Hungary S-05-004 Machine learning for predicting drug-target interactions Hiroshi Mamitsuka, Japan T41: POST TRAUMATIC STRESS DISORDERS S-06 09:30–11:00 PTSD-focused eHealth interventions Chair: Soraya Seedat, South Africa Co-Chair: Miranda Olff, The Netherlands S-06-001 Development and use of the Global Psychotrauma Scale (GPS) Miranda Olff, The Netherlands S-06-002 Development of the COVID Coach mApp based PTSD Coach Beth Jaworski, USA S-06-003 Preliminary efficacy of a mental health self-management mApp for PTSD in clinicians during COVID-19 Leigh van den Heuvel, South Africa S-06-004 Feasibility and acceptability of a clinician supported PTSD Coach intervention Erine Bröcker, South Africa T56: STEM CELLS AND ORGANOIDS S-07 09:30–11:00 In vitro models of psychiatric disorders Chair: Vincent Millischer, Austria Co-Chair: Carl Sellgren-Majkowitz, Sweden S-07-001 Synapse refinement, organoids and schizophrenia Carl Sellgren-Majkowitz, Sweden S-07-002 Modelling affective disorders with induced pluripotent stem cells Krishna Vadodaria, USA S-07-003 Modelling prenatal maternal stress in organoids Cristiana Cruceanu, Germany S-07-004 Cerebral organoids to model neurodevelopmental disorders Nina Corsini, Austria T49: PSYCHOPHARMACOLOGY S-08 09:30–11:00 How safe are psychotropic drugs and ECT in pregnancy? Chair: Angelika Wieck, United Kingdom Co-Chair: Ian Jones, United Kingdom S-08-001 Why are reproductive safety data so difficult to inter- pret?: The example of antidepressants Ian Jones, United Kingdom S-08-002 What do we know about the effects of antipsychotics and mood stabilizers on the development of children exposed in utero? Angelika Wieck, United Kingdom MON